Isolation and characterization of DNA from the plasma of cancer patients

Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I

Rigby, P. W. J., Dieckmann, M., Rhodes, C., & Berg, P. R. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90052-3 · Cited by 11,400

Untitled work

(1977) · PubMed · Cited by 1,801

Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system.

Anker, P., Stroun, M., & Maurice, P. A. (1975) · PubMed · Cited by 234

Excretion of Deoxyribonucleic Acid by Lymphocytes Stimulated with Phytohemagglutinin or Antigen

ROGERS, J. C., Boldt, D. H., Kornfeld, S. A., Skinner, S. A. M., & VALERI, C. R. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.7.1685 · Cited by 158

Circulating Nucleic Acids in Higher Organisms

Stroun, M., Anker, P., Maurice, P. A., & Gahan, P. B. (1977) · International review of cytology · doi:10.1016/s0074-7696(08)60225-9 · Cited by 106

Circulating DNA in systemic lupus erythematosus. Isolation and characterization.

Steinman, C. R. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111278 · Cited by 99

Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans.

Wieczorek, A. J., Rhyner, C., & Block, L. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.10.3455 · Cited by 97

Circulating DNA in systemic lupus erythematosus

Steinman, C. R. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90789-7 · Cited by 95

Cell-surface-associated nucleic acid in tumorigenic cells made visible with platinum-pyrimidine complexes by electron microscopy.

Aggarwal, S. K., Wagner, R. W., McAllister, P. K., & Rosenberg, B. H. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.3.928 · Cited by 79

Nucleic acids spontaneously released by living frog auricles

Stroun, M., & Anker, P. (1972) · Biochemical Journal · doi:10.1042/bj1280100pb · Cited by 69

Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics

Choi, I. S., Kato, S., Fanta, P. T., Leichman, L., Okamura, R., Raymond, V. M., Lanman, R. B., Lippman, S. M., & Kurzrock, R. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0965 · Cited by 23

The Biology of Circulating Nucleic Acids in Plasma and Serum (CNAPS)

Gahan, P. B., & Stroun, M. (2010) · Nucleic acids and molecular biology · doi:10.1007/978-3-642-12617-8_10 · Cited by 23

Diagnosis of pancreatico-biliary malignancy: Detection of gene mutations in plasma and stool

Mulcahy, H. E., & Farthing, M. J. G. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_4.s114 · Cited by 23

TP53, EGFR and PIK3CA gene variations observed as prominent biomarkers in breast and lung cancer by plasma cell-free DNA genomic testing

Savlı, H., Sertdemir, N., Aydın, D., Dursun, B., Kurtaş, Ö., Reka, S., Akkoyunlu, D. S., KESKİN, S. E., Uygun, K., Özden, E., et al. (2019) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2019.05.005 · Cited by 22

k‐ras Point Mutations in the Supernatants of Pancreatic Juice and Bile Are Reliable for Diagnosis of Pancreas and Biliary Tract Carcinomas Complementary to Cytologic Examination

Yamashita, K., Kida, Y., Shinoda, H., Kida, M., & Okayasu, I. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00739.x · Cited by 22

Sequence-Based Platforms for Discovering Biomarkers in Liquid Biopsy of Non-Small-Cell Lung Cancer

Brockley, L. J., Souza, V. G. P., Forder, A., Pewarchuk, M. E., Erkan, M., Telkar, N., Benard, K., Trejo, J., Stewart, M. D., Stewart, G. L., et al. (2023) · Cancers · doi:10.3390/cancers15082275 · Cited by 22

Specific real-time PCR vs. fluorescent dyes for serum free DNA quantification

Chiminqgi, M., Moutereau, S., Pernet, P., Conti, M., Barbu, V. D., Lemant, J., Sacko, M., Vaubourdolle, M., & Loric, S. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.191 · Cited by 21

Early detection of pre-malignant lesions in a KRASG12D-driven mouse lung cancer model by monitoring circulating free DNA

Rakhit, C. P., Trigg, R. M., Quesne, J. P. C. L., Kelly, M., Shaw, J., Pritchard, C. A., & Martins, L. M. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.036863 · Cited by 21

Modeling clonal structure over narrow time frames via circulating tumor DNA in metastatic breast cancer

Weber, Z., Collier, K. A., Tallman, D., Forman, J., Shukla, S. A., Asad, S., Rhoades, J., Freeman, S. S., Parsons, H. A., Williams, N. O., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00895-x · Cited by 20

Hide and seek: tell-tale signs of breast cancer lurking in the blood

Guttery, D. S., Blighe, K., Page, K., Marchese, S. D., Hills, A., Coombes, R. C., Stebbing, J., & Shaw, J. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9414-4 · Cited by 20

Extracellular DNA in blood products and its potential effects on transfusion

Li, Y., Yang, D., Yang, Q., Fu, C., & Huang, Y. (2020) · Bioscience Reports · doi:10.1042/bsr20192770 · Cited by 20

Plasma DNA, prediction and post-traumatic complications

Rainer, T. H. (2001) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00653-2 · Cited by 20

Molecular genetic characteristics of lung cancer—useful as ‘real’ tumor markers?

Fleischhacker, M., Beinert, T., & Possinger, K. (1999) · Lung Cancer · doi:10.1016/s0169-5002(99)00043-4 · Cited by 20

Circulating DNA

Gahan, P. B. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1368.003 · Cited by 19

K- ras Mutations in Sera of Patients with Colorectal Neoplasias and Long-standing Inflammatory Bowel Disease

Borchers, R., Heinzlmann, M., Zahn, R., Witter, K., Martin, K., Loeschke, K., & Folwaczny, C. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520212505 · Cited by 19

A Targeted Q-PCR-Based Method for Point Mutation Testing by Analyzing Circulating DNA for Cancer Management Care

Thierry, A. R. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3360-0_1 · Cited by 18

Nanopore-based consensus sequencing enables accurate multimodal tumor cell-free DNA profilingPreprint

Chen, L., Jager, M., Rebergen, D., Brink, G. J., van den Ende, T., Vanderlinden, W., Kolbeck, P. J., Pagès-Gallego, M., van der Pol, Y., Besselink, N. J. M., et al. (2025) · Genome Research · doi:10.1101/gr.279144.124 · Cited by 18

Integrating artificial intelligence with circulating tumor DNA for non-small cell lung cancer: opportunities, challenges, and future directions

Thalambedu, N., Balla, M., Sivasubramanian, B. P., Sadaram, P., Malla, K. P., Vasipalli, K., & Kakadia, S. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1612376 · Cited by 19

A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer

Lee, I., Ahn, J., Kim, K., Okugawa, Y., Toiyama, Y., Hur, H., & Goel, A. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01461-3 · Cited by 16

B1 Sequence–Based Real-Time Quantitative PCR: A Sensitive Method for Direct Measurement of Mouse Plasma DNA Levels After Gamma Irradiation

Zhang, H., Zhang, S. B., Sun, W., Yang, S., Zhang, M., Wang, W., Liu, C., Zhang, K., Swarts, S. G., Fenton, B. M., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.03.009 · Cited by 16

Non-Invasive Detection of Esophageal Cancer using Genetic Changes in Circulating Cell-Free DNA.

Ghorbian, ‪., & Ardekani, A. M. (2012) · Europe PMC (PubMed Central) · Cited by 16

Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer

Sassu, C. M., Palaia, I., Boccia, S. M., Caruso, G., Perniola, G., Tomao, F., Donato, V. D., Musella, A., & Muzii, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413650 · Cited by 16

MicroRNA (miRNA) expression profiling of peripheral blood samples in multiple myeloma patients using microarray.

Yyusnita, Norsiah, Zakiah, I., Chang, K. M., Purushotaman, V., Zubaidah, Z., & Jamal, R. A. (2012) · PubMed · Cited by 16

Using Liquid Biopsy in the Treatment of Patient with OS

Shulman, D. S., & Crompton, B. D. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43032-0_9 · Cited by 15

Circulating extracellular vesicles provide valuable protein, but not DNA, biomarkers in metastatic breast cancer

Tkach, M., Hego, C., Michel, M., Darrigues, L., Pierga, J., Bidard, F., Théry, C., & Proudhon, C. (2022) · Journal of Extracellular Biology · doi:10.1002/jex2.51 · Cited by 15

Tumor-specific DNA in plasma of breast cancer patients

Shao, Z., & Nguyen, M. T. N. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200204000-00003 · Cited by 15

Evaluation of Mycobacterium tuberculosis derived cell-free DNA using pleural fluid and paired plasma samples for the diagnosis of pleural tuberculosis

Sharma, P., Gupta, R. K., Anthwal, D., Dass, M., Yadav, R., Behera, A., Sethi, S. K., Singhal, R., Dhooria, S., Aggarwal, A. N., et al. (2023) · Tuberculosis · doi:10.1016/j.tube.2023.102369 · Cited by 14

Elevated Cell-Free DNA Measured by a Simple Assay Is Associated With Increased Rate of Colorectal Cancer Relapse

Czeiger, D., Shaked, G., Sebbag, G., Vakhrushev, A., Flomboym, A., Lior, Y., Belochitski, O., Ariad, S., & Douvdevani, A. (2016) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqw068 · Cited by 14

Efficacy of assessing circulating cell-free DNA using a simple fluorescence assay in patients with triple-negative breast cancer receiving neoadjuvant chemotherapy: a prospective observational study

Park, K., Woo, M., Kim, J. E., Ahn, J., Jung, K. H., Roh, J., Gong, G., & Kim, S. (2017) · Oncotarget · doi:10.18632/oncotarget.23520 · Cited by 14

Circulating Cell-Free DNA in Cancer

Pinzani, P., Salvianti, F., Orlando, C., & Pazzagli, M. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0733-5_13 · Cited by 14

Liquid biopsy challenge and hope in colorectal cancer

Burz, C. C., Rosca, A., Pop, V.-V., Buiga, R., Aldea, C. O., Samaşcă, G., Silaghi, C. N., Sur, D. G., Lupan, I., & Pricopie, A. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1597708 · Cited by 13

BRCA Mutational Status is a Promising Predictive Biomarker for Platinum- based Chemotherapy in Triple-Negative Breast Cancer

Tazzite, A., Jouhadi, H., Benider, A., & Nadifi, S. (2020) · Current Drug Targets · doi:10.2174/1389450121666200203162541 · Cited by 13

Emerging HER2-directed therapeutic agents for gastric cancer in early phase clinical trials

Lote, H., & Chau, I. (2022) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2030311 · Cited by 13

Extracellular DNA Level in the Blood of Irradiated Rats

Vg, V., Belokhvostov, A. S., Ss, S., Vasilyeva, I., & Voskresenskiĭ, A. M. (1992) · International Journal of Radiation Biology · doi:10.1080/09553009214552611 · Cited by 13

Peritoneal Cell-Free Tumor DNA is a Biomarker of Locoregional and Peritoneal Recurrence in Resected Pancreatic Ductal Adenocarcinomas

Leick, K. M., Tomanek‐Chalkley, A., Coleman, K. L., & Chan, C. H. F. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-13701-2 · Cited by 12

Recent advances in exploring new blood-based biomarkers for the early diagnosis of gastric cancer

Peng, X., Ma, Q., & Han, D. (2024) · Science China Chemistry · doi:10.1007/s11426-024-2189-1 · Cited by 12

Early Detection of Relapse by ctDNA Sequencing in a Patient with Metastatic Thymic Tumor and MEN1 Mosaicism

Lagarde, A., Collen, L. L., Boulagnon‐Rombi, C., Brixi, H., Durlach, A., Mougel, G., Cuny, T., Delemer, B., Barlier, A., & Romanet, P. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac454 · Cited by 12

Cell-free tumor DNA: Emerging reality in oral squamous cell carcinoma

Babji, D., Nayak, R. S., Bhat, K. G., & Kotrashetti, V. (2019) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_36_19 · Cited by 12

Detection of microsatellite alterations in nipple discharge accompanied by breast cancer

Miyazaki, M., Tamaki, Y., Sakita, I., Fujiwara, Y., Kadota, M., Masuda, N., Ooka, M., Ohnishi, T., Ohue, M., Sekimoto, M., et al. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006336110322 · Cited by 12

A standardised methodology for the extraction and quantification of cell-free DNA in cerebrospinal fluid and application to evaluation of Alzheimer’s disease and brain cancers

Takousis, P., Devonshire, A. S., Redshaw, N. M., von Baumgarten, L., Whale, A. S., Jones, G. M., Fernández-González, A., Martin, J., Foy, C. A., Alexopoulos, P., et al. (2022) · New Biotechnology · doi:10.1016/j.nbt.2022.10.001 · Cited by 11

Circulating tumor DNA (ctDNA) in adjuvant therapy of early stage colon cancer: current status and future perspectives

Merk, C., Martling, A., Lindberg, J., Benhaïm, L., Taı̈eb, J., & Lind, P. (2022) · Acta Oncologica · doi:10.1080/0284186x.2022.2033831 · Cited by 11

Comparison of phenomics and cfDNA in a large breast screening population: the Breast Screening and Monitoring Study (BSMS)

Stebbing, J., Takis, P. G., Sands, C. J., Maslen, L., Lewis, M. R., Gleason, K. L. T., Page, K., Guttery, D. S., Fernández-García, D., Primrose, L., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02591-z · Cited by 11

Enrichment technique to allow early detection and monitor emergence of KRAS mutation in response to treatment

Kitagawa, Y., Okumura, K., Watanabe, T., Tsukamoto, K., Kitano, S., Nankinzan, R., Suzuki, T., Hara, T., Soda, H., Denda, T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47700-9 · Cited by 10

Post-Biopsy Cell-Free DNA From Blood: An Open Window on Primary Prostate Cancer Genetics and Biology

Corbetta, M., Chiereghin, C., simone, I. D., Soldà, G., Zuradelli, M., Giunta, M., Giovanni Lughezzani, A., Buffi, N. M., Hurle, R. F., Saita, A. R., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.654140 · Cited by 10

The History and Future of Basic and Translational Cell-Free DNA Research at a Glance

Gahan, P. B., Schwarzenbach, H., & Anker, P. (2022) · Diagnostics · doi:10.3390/diagnostics12051192 · Cited by 10

Analysis of GD2/GM2 synthase mRNA as a biomarker for small cell lung cancer

Chen, L., Brown, A. B., Cheung, I. Y., Cheung, N. V., Kris, M. G., & Krug, L. M. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.04.009 · Cited by 10

Targeting lethal minimal residual disease in small cell lung cancer

Patel, J. D., Krug, L. M., Azzoli, C. G., Gomez, J. E., Kris, M. G., & Miller, V. A. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50018 · Cited by 10

Cell-Free DNA as a New Biomarker of IVF Success, Independent of Any Infertility Factor, Including Endometriosis

Alves, M. M. C., Oliani, L., Almeida, M., Cardoso, H. J., Oliani, A. H., Breitenfeld, L., & Ramalhinho, A. C. (2023) · Diagnostics · doi:10.3390/diagnostics13020208 · Cited by 9

Free circulating DNA based colorectal cancer screening from peripheral blood: the possibility of the methylated septin 9 gene marker

Tóth, K., Galamb, O., Spisák, S., Wichmann, B., Sípos, F., Leiszter, K., Molnár, J., Molnar, B. A., & Tulassay, Z. (2009) · Orvosi Hetilap · doi:10.1556/oh.2009.28625 · Cited by 9

Comparisons between capillary zone electrophoresis and real-time PCR for quantification of circulating DNA levels in human sera

Sang, F., & Ren, J. (2006) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.04.026 · Cited by 9

Cell-Free DNA as a Biomarker in the Context of Cancer, Viruses, and Methylation

Stebbing, J., & Bower, M. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis023 · Cited by 9

Detecting Rare Mutations Associated with Cancer Risk

Wilson, V. L. (2001) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200101040-00005 · Cited by 8

La biopsie liquide

Thierry, A. R., & Tanos, R. (2018) · médecine/sciences · doi:10.1051/medsci/2018208 · Cited by 8

Feasibility of Cell-Free DNA Measurement from the Earlobe during Physiological Exercise Testing

Haller, N., Tomaskovic, A., STÖGGL, T. L., Simon, P. D., & Neuberger, E. W. I. (2022) · Diagnostics · doi:10.3390/diagnostics12061379 · Cited by 7

Cell-Free DNA for the Detection of Pancreatic, Liver and Upper Gastrointestinal Cancers: Has Progress Been Made?

Gall, T., Frampton, A. E., Krell, J., Habib, N. A., Castellano, L., Stebbing, J., & Jiao, L. R. (2013) · Future Oncology · doi:10.2217/fon.13.152 · Cited by 7

Circulating Cell-Free DNA Levels in Patients with Metastatic Renal Cell Carcinoma

Rouvinov, K., Mermershtain, W., Dresler, H., Ariad, S., Riff, R., Shani-Shrem, N., Keizman, D., & Douvdevani, A. (2017) · Oncology Research and Treatment · doi:10.1159/000479523 · Cited by 7

Use of circulating nucleic acids, metabolites, and proteins as clinical biomarkers for earlier prognosis and diagnosis of disease

Ananthamohan, K., Jha, R. M., & Sharma, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814259-2.00005-4 · Cited by 7

Low-Pass Whole Genome Sequencing of Cell-Free DNA from Cerebrospinal Fluid: A Focus on Pediatric Central Nervous System Tumors

O’Halloran, K., Christodoulou, E., Paulson, V., Cole, B., Margol, A., Biegel, J. A., Leary, S. E. S., Lockwood, C. M., & Crotty, E. E. (2024) · Clinical Chemistry · doi:10.1093/clinchem/hvae140 · Cited by 6

Emerging Role of Blood-based Biomarkers in Sarcomas

Shulman, D. S., & Crompton, B. D. (2025) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2025.04.002 · Cited by 6

When Tissue Is the Issue

Paulson, V., Konnick, E. Q., & Lockwood, C. M. (2022) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2022.05.005 · Cited by 6

The potential of circulating cell-free RNA in CNS tumor diagnosis and monitoring: A liquid biopsy approach

Heming, C. P., & Aran, V. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104504 · Cited by 7

Low correspondence of EGFR mutations in tumor tissue and paired serum of non-small-cell lung cancer patients

Song, G., Ren, J., Zhang, L., Di, L.-J., Yuan, Y., Yu, J., & Jia, J. (2010) · Chinese Journal of Cancer Research · doi:10.1007/s11670-010-0027-6 · Cited by 6

Cell-Free DNA, MicroRNAs, Proteins, and Peptides as Liquid Biopsy Biomarkers in Prostate Cancer and Bladder Cancer

Chen, H., Xu, C., Fang, Z., & Mao, S. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3346-5_11 · Cited by 6

Cell-free nucleic acids in urine as potential biomarkers of kidney disease

Gyurászová, M., Kovalčíková, A. G., Bábíčková, J., Hodosy, J., & Tóthová, Ľ. (2018) · Journal of Applied Biomedicine · doi:10.1016/j.jab.2018.01.007 · Cited by 6

Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?

Yu, M., Zhu, Y., Teng, L., Cui, J., & Su, Y. (2021) · Journal of Oncology · doi:10.1155/2021/6627241 · Cited by 6

Cell-Free Methylated PTGER4 and SHOX2 Plasma DNA as a Biomarker for Therapy Monitoring and Prognosis in Advanced Stage NSCLC Patients

Fleischhacker, M., Arslan, E., Reinicke, D., Eisenmann, S., Theil, G., Kollmeier, J., Schäper, C., Grah, C., Klawonn, F., Holdenrieder, S., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13132131 · Cited by 6

Blood Tests for Colorectal Cancer Screening in the Standard Risk Population

Symonds, E. L., & Young, G. P. (2015) · Current Colorectal Cancer Reports · doi:10.1007/s11888-015-0293-2 · Cited by 6

New evaluation of plasma DNA microsatellite analysis in patients with TCC of the urinary bladder.

Fornari, D., Steven, K. E., Hansen, A., Vibits, H., Jepsen, J. V., Poulsen, A. L., Schwartz, M., & Horn, T. D. (2004) · PubMed · Cited by 6

Circulating extracellular vesicle DNA (EV-DNA) and cell-free DNA in ovarian cancer: pathological relevance and diagnostic applications

Guanzon, D., Sankar, R., Lodha, P., Purushothaman, R., Huang, S., Jayabalan, N., Dahanayake, M. H., Ahmed, E., Han, P., Masud, M. K., et al. (2026) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2025.120 · Cited by 5

Extracting regulatory active chromatin footprint from cell-free DNA

Lai, K., Dilger, K., Cunningham, R. M., Lam, K., Boquiren, R., Truong, K. P., Louie, M. C., Rava, R. P., & Abdueva, D. A. (2024) · Communications Biology · doi:10.1038/s42003-024-06769-3 · Cited by 5

Oncogenic mutations of PIK3CA and HRAS in carcinoma of cervix in South Indian women

Kumari, K. G., Mandarapu, R., & Sudhakar, G. (2017) · Journal of Oncological Sciences · doi:10.1016/j.jons.2017.10.004 · Cited by 5

Our "Shagreen leather" is our problem. And we have to solve it. 3. A missing link

Kordyum, V. A. (2003) · Biopolymers and Cell · doi:10.7124/bc.000678 · Cited by 5

Liquid Biopsy in Multiple Myeloma

Mithraprabhu, S., & Spencer, A. G. (2018) · InTech eBooks · doi:10.5772/intechopen.72652 · Cited by 4

Transfer of genetic information in an organism

Kordyum, V. A., Shpylova, S. P., Andrienko, V. I., Sukhorada, O. M., Рубан, Т. А., & Deryabina, О. G. (2005) · Cell Biology International · doi:10.1016/j.cellbi.2004.11.005 · Cited by 4

Extracellular genetic materials and their application in clinical practice

Koçana, C. Ç., Toprak, S. F., & Sözer, S. (2020) · Cancer Genetics · doi:10.1016/j.cancergen.2020.12.006 · Cited by 4

Recovery of Small DNA Fragments from Serum Using Compaction Precipitation

Vu, B. V., Anthony, K. L., Strych, U., & Willson, R. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051863 · Cited by 4

Phase I Study of the Administration of Low-dose Perioperative Human Atrial Natriuretic Peptide in Patients With Resectable Colorectal Cancer

Takahashi, H., TAKEDA, T., Nishizawa, Y., Ogino, T., Miyoshi, N., Matsuda, C., Yamamoto, H., Mizushima, T., Doki, Y., & Eguchi, H. (2020) · Anticancer Research · doi:10.21873/anticanres.14536 · Cited by 4

Marcadores tumorais no câncer de pulmão: um caminho para a terapia biológica

Pacheco, F. A., Paschoal, M. E. M., & Carvalho, M. D. G. (2002) · Jornal de Pneumologia · doi:10.1590/s0102-35862002000300006 · Cited by 4

Prostate Cancer: Detection of Free Tumor-Specific DNA in Blood and Bone Marrow

Schwarzenbach, H., & Pantel, K. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8442-3_34 · Cited by 4

Advance in human free circulating DNA

Ying, H. U. (2008) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2008.00815 · Cited by 3

Comparison of SUVmax Values Obtained from F-18 FDG PET/CT and Cell-free DNA Levels Measured from Plasma in Oncology Patients

Çelik, F., Tan, Y. Z., Özdemir, S., & Sılan, F. (2019) · Molecular Imaging and Radionuclide Therapy · doi:10.4274/mirt.galenos.2019.60352 · Cited by 3

Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomas

Meriranta, L., Pitkänen, E., & Leppä, S. (2023) · Seminars in Hematology · doi:10.1053/j.seminhematol.2023.06.006 · Cited by 3

Profile of Proteins Complexed with Circulating DNA of a Lung Cancer Patient

Kawamura, M. T., Paschoal, M. E. M., & Carvalho, M. D. G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06590.x · Cited by 3

Autotransformation of mammalian cells

Арнольдович, К. В., Shpilevaya, S. P., Рубан, Т. А., Sukhorada, O. M., & Andrienko, V. I. (2005) · Biopolymers and Cell · doi:10.7124/bc.0006e4 · Cited by 3

Quality assurance and standardization in view of non-invasive prenatal testing (NIPT)

Schenk, P. W. (2016) · Journal of Laboratory Medicine · doi:10.1515/labmed-2016-0066 · Cited by 3

Identification of Somatic Mutations in Thirty-year-old Serum Cell-free DNA From Patients With Breast Cancer: A Feasibility Study

Ritter, M., Paradiso, V., Widmer, P., Garofoli, A., Quagliata, L., Eppenberger‐Castori, S., Soysal, S. D., Muenst, S. E., Ng, C. K. Y., Piscuoglio, S., et al. (2020) · Clinical Breast Cancer · doi:10.1016/j.clbc.2020.04.005 · Cited by 3

EV-encapsulated extracellular microRNAs as orchestrators of systemic communication in immunity and inflammation

Chen, J., Li, J., Yin, X., Fu, Z., Chen, X., & Zhang, C.-Y. (2026) · Immunity & Inflammation · doi:10.1007/s44466-026-00042-4 · Cited by 2

Circulating cell-free DNA as predictors of Parkinson's disease

Patil, K. S., Lange, J., Constantine, A., Maple‐Grødem, J., Tysnes, O., Alves, G. W., DiFrancisco‐Donoghue, J., & Møller, S. G. (2025) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2025.107919 · Cited by 2

The contribution of the 20th century discoveries on the circulating DNA as biomarkers for cancer screening

Alves, G., Chantre-Justino, M., & Delmonico, L. (2020) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202020200919 · Cited by 2

Stance of MRD in Non-Hodgkin’s Lymphoma and its upsurge in the novel era of cell-free DNA

Garg, S., Kumar, A., & Gupta, R. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02635-4 · Cited by 2

Homo sapiens as physician and patient: a view from Darwinian medicine.

Román‐Franco, A. A. (2013) · PubMed · Cited by 2

The value of low-molecular-weight DNA of blood plasma in the diagnostic of the patological processes of different genesis

Vasilyeva, I., & Zinkin, V. N. (2013) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20135903358 · Cited by 2

Blood levels of extracellular DNA in irradiated rats

Vg, V., Belokhvostov, A. S., Ss, S., Васильева, И. Н., & Voskresenskii, A. M. (1992) · Bulletin of Experimental Biology and Medicine · doi:10.1007/bf00791515 · Cited by 2

Obesity Leads to Elevated Level of Circulating Cell-Free DNA

Baig, A. A. (2018) · Current Trends in Biomedical Engineering & Biosciences · doi:10.19080/ctbeb.2018.16.555944 · Cited by 2

Prenatal Tarama Testleri ve Hücreden Bağımsız Fetal DNA

Şirin, F. B. (2019) · SDÜ Tıp Fakültesi Dergisi · doi:10.17343/sdutfd.605545 · Cited by 2

Rapid Isolation and Detection of Cell Free Circulating DNA and Other Disease Biomarkers Directly from Whole Blood

Krishnan, R., & Heller, M. J. (2010) · Springer eBooks · doi:10.1007/978-90-481-9382-0_34 · Cited by 2

Cell-free DNA in hepatocellular carcinoma

Coto‐Llerena, M., Terracciano, L., von Flüe, M., Ng, C. K. Y., & Piscuoglio, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819178-1.00019-8 · Cited by 2

Diagnostische Bedeutung zirkulierender DNA- Fragmente in der Onkologie. Diagnostic importance of circulating DNA fragments in oncology

Holdenrieder, S., von Pawel, J., Schalhorn, A., & Stieber, P. (2005) · Journal of Laboratory Medicine · doi:10.1515/jlm.2005.019 · Cited by 2

Microsatellite Alterations as Diagnostic and Prognostic Molecular Markers in Patients With Cancer

Taback, B., & Hoon, D. S. �. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-791-8_19 · Cited by 2

Urinary cell-free DNA as a noninvasive liquid biopsy for hepatocellular carcinoma: a novel tool for diagnostics and monitoringPreprint

Kim, A. K., Lin, S. Y., Liu, H.-N., Jain, S., Gade, T. P. F., Shieh, F., Chao, M., Hamilton, J. P., Hann, H., Chang, T.-T., et al. (2021) · medRxiv · doi:10.1101/2021.12.03.21266943 · Cited by 2

Neoplastic Characteristics of the DNA Found in the Plasma of Cancer Patients

Stroun, M., Anker, P., Maurice, P. A., Lyautey, J., Lederrey, C., & Beljanski, M. (2009) · Oncology · doi:10.1159/000226740 · Cited by 743

Quantification of Circulating DNA in the Plasma and Serum of Cancer Patients

Taback, B., O'Day, S. J., & Hoon, D. S. �. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1318.004 · Cited by 91

Plasma DNA of Cancer Patients

Jaiwang, W., Tangvarasittichai, S., Potup, P., & Tangvarasittichai, O. (2011) · The Public Health Journal of Burapha University

DNA fragments in plasma of cancer patients

Jahr, S. (2001) · KOPS (University of Konstanz)

The Importance of Careful Blood Processing in Isolation of Cell‐Free DNA

PAGE, K., Powles, T., Slade, M. J., Bella, M. T. D., Walker, R. A., Coombes, R. C., & Shaw, J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1368.042 · Cited by 71